The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 328:815 March 18, 1993 Number 11
NextNext

Anaphylactic Reaction to Gonadotropin-Releasing Hormone

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
To the Editor: Anaphylactic reactions in patients receiving pulsatile gonadotropin-releasing hormone (GnRH) are rare.1 We describe a patient who had such a reaction when given GnRH intravenously after having received pulsatile subcutaneous GnRH therapy for 10 weeks.

The patient was a 31-year-old man with infertility due to severe oligospermia. His sexual development and physical examination were normal. The plasma follicle-stimulating hormone, luteinizing hormone, and testosterone concentrations were 8 mIU per milliliter, 10 mIU per milliliter, and 450 ng per deciliter (15.6 nmol per liter), respectively. The patient underwent an intravenous GnRH stimulation test with 100 µg of GnRH and then . . . [Full Text of this Article]

References



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.